Use of Propranolol for Infantile Hemangiomas
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Propranolol in the Treatment of Infantile Haemangiomas: Lessons From the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce Survey
Br J Dermatol 2015 Oct 16;[EPub Ahead of Print], E Wedgeworth, M Glover, AD Irvine, I Neri, E Baselga Torres, TH Clayton, PE Beattie, JV Bjerre, NP Burrows, R Foelster-Holst, L Hedelund, A Hernandez-Martin, H Audrain, K Bhate, SJ Brown, S Baryschpolec, S Darne, A Durack, V Dvorakova, J Gach, N Goldstraw, H Goodyear, S Grabcyznska, D Greenblatt, J Halpern, RM Hearn, S Hoey, B Hughes, R Jayaraj, EK Johansson, M Lam, S Leech, GM O'Regan, D Morrison, W Porter, R Ramesh, T Schill, L Shaw, AE Taylor, R Taylor, J Thomson, P Tiffin, M Tsakok, SR Janmohamed, B Laguda, T McPherson, A Oranje, A Patrizi, J Ravenscroft, H Shahidullah, L Soloman, A Svensson, CF Wahlgren, PH Hoeger, C FlohrFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.